| 10160744 |
Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor |
Hervé Geneste, Frauke Pohlki, Ana-Lucia Relo, Liliane Unger, Karsten Wicke |
2018-12-25 |
|
| 10118926 |
Tricyclic quinoline and quinoxaline derivatives |
Hannes Fiepko KOOLMAN, Wilfried Braje, Helmut Mack, Ana-Lucia Relo, Karla Drescher +5 more |
2018-11-06 |
$227,839,000 |
| 9994568 |
Tricyclic quinoline and quinoxaline derivatives |
Hannes Fiepko KOOLMAN, Wilfried Braje, Helmut Mack, Ana-Lucia Relo, Karla Drescher +3 more |
2018-06-12 |
$512,591,000 |
| 9573950 |
Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators |
Gisela Backfisch, Margaretha Henrica Maria Bakker, Günter BLAICH, Wilfried Braje, Karla Drescher +9 more |
2017-02-21 |
$237,163,000 |
| 9540376 |
Hexahydrodiazepinoquinolines carrying a substituted alkyl radical |
Gisela Backfisch, Margaretha Henrica Maria Bakker, Günter BLAICH, Wilfried Braje, Karla Drescher +7 more |
2017-01-10 |
$139,904,000 |
| 9388141 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot, Karla Drescher +1 more |
2016-07-12 |
$246,047,000 |
| 9388148 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot, Karla Drescher +1 more |
2016-07-12 |
$246,047,000 |
| 9376396 |
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor |
Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot, Scott Mittelstadt +2 more |
2016-06-28 |
$672,150,000 |
| 9169253 |
Tricyclic quinoline and quinoxaline derivatives |
Hannes Fiepko KOOLMAN, Wilfried Braje, Helmut Mack, Ana-Lucia Relo, Karla Drescher +3 more |
2015-10-27 |
$183,930,000 |
| 8969552 |
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
Karla Drescher, Liliane Unger, Sean Colm Turner, Wilfried Braje, Roland Grandel +1 more |
2015-03-03 |
$62,912,000 |
| 8921406 |
5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors |
Wilhelm Amberg, Astrid Netz, Andreas Kling, Michael Ochse, Udo Lange +2 more |
2014-12-30 |
$164,094,000 |
| 8772313 |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor |
Frauke Pohlki, Liliane Unger, Ana-Lucia Relo, Karsten Wicke, Min Zhang |
2014-07-08 |
|
| 8710059 |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor |
Frauke Pohlki, Liliane Unger, Ana-Lucia Relo, Karsten Wicke, Min Zhang |
2014-04-29 |
|
| 8642642 |
Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
Roland Grandel, Wilfried Braje, Sean Colm Turner, Udo Lange, Karla Drescher +2 more |
2014-02-04 |
|
| 8507469 |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
Thomas Schultz, Wilfried Braje, Sean Colm Turner, Udo Lange, Karla Drescher +4 more |
2013-08-13 |
$26,628,000 |
| 8497273 |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
Roland Grandel, Wilfried Braje, Sean Colm Turner, Udo Lange, Karla Drescher +1 more |
2013-07-30 |
$27,275,000 |
| 8492540 |
1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
Wilfried Braje, Sean Colm Turner, Udo Lange, Hervé Geneste, Karla Drescher +3 more |
2013-07-23 |
$58,743,000 |
| 8486984 |
Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
Karla Drescher, Liliane Unger, Sean Colm Turner, Wilfried Braje, Roland Grandel |
2013-07-16 |
$15,491,000 |
| 8476275 |
N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor |
Wilfried Braje, Wilfried Lubisch, Roland Grandel, Karla Drescher, Hervé Geneste +3 more |
2013-07-02 |
$21,808,000 |
| 8470810 |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
Karla Drescher, Liliane Unger, Sean Colm Turner, Wilfried Braje, Roland Grandel +4 more |
2013-06-25 |
$15,222,000 |
| 8440694 |
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor |
Sean Colm Turner, Wilfried Braje, Udo Lange, Karla Drescher, Karsten Wicke +4 more |
2013-05-14 |
$26,758,000 |
| 8440626 |
Antineoplastic peptides |
Wilhelm Amberg, Teresa Barlozzari, Harald Bernard, Ernst Buschmann, Hans-Guenther Hege +7 more |
2013-05-14 |
$26,758,000 |
| 8383641 |
Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
Roland Grandel, Wilfried Braje, Sean Colm Turner, Udo Lange, Karla Drescher +1 more |
2013-02-26 |
$9,076,000 |
| 8362010 |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
Frauke Pohlki, Karla Drescher, Karsten Wicke, Liliane Unger, Ana-Lucia Relo +5 more |
2013-01-29 |
$21,494,000 |
| 8343959 |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
Frauke Pohlki, Karla Drescher, Karsten Wicke, Liliane Unger, Ana-Lucia Relo +6 more |
2013-01-01 |
|
